1 – 35 of 35
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours : a multicentre retrospective observational cohort study
(
- Contribution to journal › Article
- 2017
-
Mark
Associations of defect mismatch repair genes with prognosis and heredity in sporadic colorectal cancer
(
- Contribution to journal › Article
- 2016
-
Mark
Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial.
(
- Contribution to journal › Article
- 2015
-
Mark
Time trends, improvements and national auditing of rectal cancer management over an 18-year period.
(
- Contribution to journal › Article
- 2013
-
Mark
Population-based data from the Swedish Colon Cancer Registry
(
- Contribution to journal › Article
- 2012
-
Mark
Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases : A randomized eortc intergroup phase ii study (EORTC 40004)
(
- Contribution to journal › Article
- 2011
-
Mark
Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer
(
- Contribution to journal › Article
- 2009
-
Mark
High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer.
(
- Contribution to journal › Article
- 2008
-
Mark
Health-related quality of life and distress in cancer patients: results from a large randomised study
(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer
(
- Contribution to journal › Article
- 2006
-
Mark
Relevance of philosophy of life and optimism for psychological distress among individuals in a stage where death is approaching
(
- Contribution to journal › Article
-
Mark
Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype
(
- Contribution to journal › Article
- 2005
-
Mark
The potential of proton beam radiation therapy in prostate cancer, other urological cancers and gynaecological cancers
(
- Contribution to journal › Article
-
Mark
The potential of proton beam radiation therapy in intracranial and ocular tumours
(
- Contribution to journal › Article
-
Mark
The potential of proton beam radiation for palliation and reirradiation
(
- Contribution to journal › Article
-
Mark
The potentials of proton beam radiation therapy in malignant lymphoma, thymoma and sarcoma
(
- Contribution to journal › Article
-
Mark
Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma
(
- Contribution to journal › Article
-
Mark
The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer
(
- Contribution to journal › Article
-
Mark
Number of patients potentially eligible for proton therapy
(
- Contribution to journal › Scientific review
-
Mark
Body mass index and risk of malignant lymphoma in Scandinavian men and women
(
- Contribution to journal › Article
-
Mark
Adjuvant chemotherapy in colorectal cancer: A joint analysis of randomised trials by the Nordic gastrointestinal tumour adjuvant therapy group
(
- Contribution to journal › Article
- 2004
-
Mark
Politikers oförmåga drabbar cancersjuka
2004) In Dagens Nyheter(
- Contribution to specialist publication or newspaper › Newspaper article
- 2003
-
Mark
Research and development of radiation therapy in clinical routines
(
- Contribution to journal › Article
-
Mark
A systematic overview of radiation therapy effects in rectal cancer
(
- Contribution to journal › Scientific review
-
Mark
Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB
(
- Contribution to journal › Article
- 2002
-
Mark
Interactions between chemotherapy, endocrine therapy and radiation
(
- Contribution to journal › Article
-
Mark
Patients above sixty years of age with Hodgkin's lymphoma treated with a new strategy
(
- Contribution to journal › Article
-
Mark
Sensitizing and protective substances in radiation therapy and predictive assays
(
- Contribution to journal › Article
-
Mark
A population-based study of the outcome for patients with first relapse of Hodgkin's lymphoma
(
- Contribution to journal › Article
- 2001
-
Mark
A systematic overview of chemotherapy effects in ovarian cancer
(
- Contribution to journal › Scientific review
-
Mark
The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of chemotherapy effects in some major tumour types--summary and conclusions
(
- Contribution to journal › Scientific review
- 2000
-
Mark
Residual mass in aggressive lymphoma--does size, measured by computed tomography, influence clinical outcome?
(
- Contribution to journal › Article
- 1995
-
Mark
Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting : the Nordic experience. The Nordic Antiemetic Trial Group
(
- Contribution to journal › Article
- 1994
-
Mark
A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis
(
- Contribution to journal › Article
- 1986
-
Mark
Comparative immunohistochemical demonstration of difucosylated carbohydrate antigens and CEA in adenomas and carcinomas of the rectum and rectosigmoid
(
- Contribution to journal › Article